Sayegh, N., Jo, Y., Ozay, Z. I., Chehade, C. H., Gebrael, G., Ostrowski, M., Campbell, P., Tripathi, N., Hu, S., Chigarira, B., Anderson, E., Ji, R., Fortuna, G. G., Thomas, V. M., Li, H., Gupta, S., Maughan, B. L., Agarwal, N., Swami, U. (2025). Survival outcomes of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving lutetium-177-PSMA-617 (Lu) based on line of therapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.82